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Abstract
Background: Germ-cell tumors (GCT) are a histologically and biologically diverse group of neoplasms
which primarily occur in the gonads but also develop at different extragonadal sites in the midline of the
body. The head and neck region including the upper respiratory tract is a very rare location for such
tumors in both children and adults, which can cause diagnostic and therapeutic difficulties.
Methods:  We describe here two new cases of multilineage tumors including sinonasal
teratocarcinosarcoma [SNTCS], and congenital oronasopharyngeal teratoma (epignathus) and compare
their features with those of a new case of a rare salivary gland anlage tumor [SGAT], an entity for which
the pathogenesis is unclear (i.e. hamartoma versus neoplasm). We correlate their presenting clinico-
pathological features and compare histologic and cytogenetic features in an attempt to elucidate their
pathogenesis and biologic potentials.
Results and discussion: Cytogenetic analysis revealed chromosomal abnormalities only in the case of
SNTCS that showed trisomy 12 and 1p deletion. Both cytogenetic abnormalities are characteristically
present in malignant germ cell tumors providing for the first time evidence that this rare tumor type indeed
might represent a variant of a germ cell neoplasm. The SGAT and epignathus carried no such cytogenetic
abnormalities, in keeping with their limited and benign biologic potential.
Conclusion: The comparison of these three cases should serve to emphasize the diversity of multilineage
tumors (hamartomas and GCT) of the upper respiratory tract in regards to their biology, age of
presentation and clinical outcomes. Malignant tumors of germ cell origins are more likely to affect adults
with insidious symptom development, while benign tumors can nevertheless cause dramatic clinical
symptoms which, under certain circumstances, can be fatal.
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Background
Upper respiratory tract tumors are relatively common
neoplasms whose frequency, distribution, histological
type, and clinical behavior are primarily determined by
the patient's age, sex and genetic aberrations [1].
Germ-cell tumors are a heterogeneous group of neo-
plasms that primarily occur in the gonads (both ovaries
and testes) but can also occur at extragonadal sites along
the midline of the body. The head and neck region includ-
ing the upper respiratory tract is a rare location for such
tumors in both children and adults and only a few cases
have been reported in the available literature [1]. Not sur-
prisingly, therefore, the pathologic evaluation and clinical
management of these tumors can be very difficult.
Malignant sinonasal tumors are very rare and represent
less than 1% of all cancers and approximately 3% of
malignancies of the head and neck region [2]. Despite
their low frequency, a variety of histological types can be
found. Sinonasal teratocarcinosarcoma (SNTCS), also
previously described as teratoid carcinosarcoma, malig-
nant teratoma, blastoma, and teratocarcinosarcoma is
among the rarest with one study revealing only 1 case
(0.5%) of SNTCS among 200 malignant sinonasal tumors
[2]. It primarily affects adults (average age 60 years) with
only 87 cases reported in the available literature [3-7]. Of
the reported cases only five were in patients younger than
20 years which includes one case in a neonate associated
with a cleft palate and congenital absence of the ipsilateral
Eustachian tube [8,9]. SNTCS is characterized by a histo-
logic combination of malignant teratoma and carcinosar-
coma with a triphasic growth pattern including epithelial,
mesenchymal, and primitive neuroectodermal compo-
nents [10]. SNTCS is highly aggressive and occurs mainly
located in the nose and paranasal sinuses although
tumors occurring in other locations including the
nasopharynx and oral cavity have been described [3,8,11]
though recently published review of 10 cases with long
follow up (up to 372 months) from a single institution
revealed significantly better outcome in patients with
SNTCS than previously reported [7].
In contrast to malignant germ cell tumors, benign terato-
mas of the oronasopharyngeal region (so called epig-
nathus) are composed of mature, highly organized
structures. They are rare congenital tumors constituting
less than 2% of all congenital teratomas, and with an inci-
dence estimated at from 1:35.000 to 1:200.000 live births
[12]. The most of epignathi are attached to the base of the
skull (hard palate) or to the mandible and are rarely asso-
ciated with other congenital anomalies [11,13-17].
The outcome and survival of newborns with epignathus
are generally unfavorable. The most important factors that
determine the outcome include: size of the tumor, degree
of facial distortion, airway obstruction, difficulties in
management and uni/bidirectional growth pattern of the
tumor [18]. Newly developed procedures including ex-
utero intra partum (EXIT) procedure may enable survival
of newborns with epignathus. The cases are complex,
however, with subsequent multidisciplinary surgical man-
agement, requiring meticulous planning [19].
Salivary gland anlage tumor [SGAT, also described as con-
genital pleomorphic adenoma] is a very rare, probably
hamartomatous tumor of the nasopharynx of neonates
[20]. Due to its histologic features this lesion can be easily
misdiagnosed as a neoplasm of a germ cell origin. SGAT
was first described by Har-El et al [21] in 1985, and a series
of nine cases was described by Dehner et al in 1994 [20].
Since then 24 cases have been described in the literature
including the case we are presenting herein [22]. It typi-
cally occurs in neonates in the midline of the nasopharynx
with a potential to cause life-threatening airway-obstruc-
tion [20].
Cytogenetic studies are particularly useful in determining
the germ cell origin of a neoplasm, particularly malignant
ones, because they frequently carry a characteristic chro-
mosomal gain of 12 p. In contrast, benign tumors (mature
teratomas) show no chromosomal abnormalities [23].
Because of their rarity, cytogenetic and molecular studies
of these upper respiratory tract tumors showing multilin-
eage histologic features have generally not been done.
Thus their origins remain largely unknown.
Herein, we describe for the first time a case of SNTCS with
trisomy 12 with a subclone characterized by an additional
deletion of 1 p. We further describe and contrast the case
with an epignathus and SGAT that showed no cytogenetic
aberrations.
Methods
Medical records and histopathological reports were retro-
spectively analyzed. All samples were processed and ana-
lyzed using routine pathology techniques, i.e. gross
examination, frozen sections (when requested) and for-
malin-fixation, paraffin-embedding for histologic exami-
nation. Hematoxylin and eosin (H&E) stain as well as
automated immunohistochemistry (IHC) were used to
characterize and diagnose these tumors.
The following primary antibodies were used in IHC:
cytokeratin AE1/3, HMB-45, epithelial membrane antigen
(EMA), S100, chromogranin, CD99 (DakoCytomation,
Carpinteria, CA); cytokeratin 5/6, smooth muscle actin
(SMA), alpha-feto protein (AFP), glial fibrillary acidic pro-
tein (GFAP), synaptophysin, neuron specific enolase
(NSE), myoglobin, myogenin, and p53 (Cell Marque, HotBMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
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Spring, AR); vimentin, desmin, bcl-2 (Ventana Medical
Systems, Tucson, AZ). Standard indirect biotin-streptavi-
din detection method with DAB chromagen was used.
Probe Design and FISH Methods
Fluorescence in situ hybridization (FISH) was performed
on 4–5 μm unstained paraffin-embedded tissue sections
utilizing the LSI 1p36/1q25 dual color DNA probe (Vysis/
Abbott, Downer's Grove, IL) and a dual-color DNA probe
mixture combining BAC probes specific for 12p13.2
(RP11-418C2 and RP11-434C1) with CEP 12 (Vysis/
Abbott) for ploidy determination. BAC clones were
selected according to their genomic location using the
UCSC Genome Browser http://www.genome.ucsc.edu/
and labeled by nick translation according to manufac-
turer's protocol (Vysis/Abbott). Briefly, 200 ng of each
rhodamine-5-dUTP labeled BAC clone was precipitated
together with 5 times Human Cot-1 DNA (Invitrogen,
Carlsbad, CA, USA) and a spectrum green alpha-satellite
probe for the centromeric region of chromosome 12. Prior
to hybridization the slides were pretreated using the VP
2000 automated slide processor (Vysis/Abbott, Inc.) fol-
lowing a modified version of the manufacturer's recom-
mended protocol. Co-denaturation of the DNA probes
and patient slide was performed on a HYBrite™ instru-
ment (Vysis/Abbott, Inc.) at 80° C for 5 minutes, fol-
lowed by an overnight hybridization at 37°C, post-wash
in 2 × SSC/0.1% NP-40 at 73° C and 2 × SSC at room tem-
perature for 2 minutes each, and counter-stain with DAPI
II. Hybridization signals were assessed in 100 interphase
nuclei and images were acquired using the Cytovision
Image Analysis System (Applied Imaging, Santa Clara,
CA).
Conventional cytogenetics
The representative tumor samples were disaggregated with
scalpels and collagenase and cultured in RPMI-1640
media supplemented with 20% fetal bovine serum and
antibiotics for 4–6 days as previously described [24]. Met-
aphase chromosomes were banded with Wright trypsin
and karyotypes were described according to established
international guidelines [25].
The case reports were shared with Creighton's University
Institutional Review Board; it is however the policy of this
Board not to review case reports.
Results
Case 1
An 85 year old African American female presented to her
primary care physician with complaint of spitting up
blood. Imaging studies of the chest did not identify a
cause. Five months later she presented with complaints of
sinus symptoms and CT scan identified a "large right nasal
polyp". Her primary care physician treated her for sinusi-
tis, but three weeks later she presented again complaining
of shortness of breath and difficulty moving air through
her right nostril. She also reported a bloody nose of three
weeks duration and the self discovery of a new nasal polyp
one week prior to presentation. On physical exam a large
polypoid lesion filled the right naris and MRI identified
an extensive right nasal passage mass eroding through the
cribriform plate of the right ethmoid sinus into the cranial
cavity (Figure 1). A tissue biopsy was obtained and two
follow-up biopsies were collected at the request of the
pathologist. Arrangements were made for radiation ther-
apy, but one month later, prior to initiation of the ther-
apy, the patient developed progressing neurologic
symptoms and subsequently died from a massive intracra-
nial hemorrhage. No autopsy was performed.
Pathology findings
Review of the biopsy materials showed an extensively
necrotic tissue with scattered viable epithelial and mesen-
chymal elements. The different elements blended mor-
phologically into one another. Atypical immature
epithelial, mesenchymal and primitive neuroectodermal
components were recognized at high magnification (Fig-
ure 2). Immunohistochemically, the epithelial compo-
nents were positive for keratins and EMA, and showed
focal positivity for AFP. The mesenchymal and neuroecto-
dermal components were positive for vimentin. HMB45,
myoglobin, myogenin and bcl-2 were uniformly negative.
Neural markers (S100, GFAP, synaptophysin, chrom-
ogranin, NSE) were focally positive in all elements, as
were CD99 and desmin. p53 stained approximately 10%
of the neuroectodermal components.
Based on the clinical presentation, histologic findings and
immunohistochemical characteristics, a diagnosis of tera-
tocarcinosarcoma was made.
Cytogenetics
Conventional cytogenetic analysis of 20 metaphase cells
identified a hyperdiploid clone characterized by trisomy
12, with an additional subclone characterized by a del(1
p). Karyotype of the tumor was described as: 47, XX,
+12[18]/47, idem, del(1)(p31.1p36.3)[2] (see Figure 2,
Table 1).
Case 2
A 30-year-old G2P1 woman presented at 29 weeks gesta-
tion with signs of polyhydramnios. Her first pregnancy
had been uneventful. She was referred to the hospital
because ultrasound revealed a large mass in the mouth of
the live female fetus filling the oral cavity but not protrud-
ing out of the mouth. Labor was induced with successful
delivery, but postnatal intubation was unsuccessful and
the infant died shortly after delivery.BMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
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Pathology findings
Post mortem examination revealed a female fetus with
growth parameters in keeping with 28 weeks of gestation.
There was no growth retardation. Petechiae were present
on the anterior chest and neck region.
A tumor was visible through the slightly opened mouth
appearing as a tongue-like structure with a blunt border
and skin-like surface. On dissection, the tumor was found
to arise from the hard palate and completely filled the oral
cavity and upper aero/digestive tract with dilatation of the
MRI revealed a large polypoid tumor mass eroding through the cribriform plate of the right ethmoid sinus into the cranial cav- ity Figure 1
MRI revealed a large polypoid tumor mass eroding through the cribriform plate of the right ethmoid sinus into 
the cranial cavity.BMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
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pharynx (Figure 3A). No transphenoidal intracranial
extension of the tumor was found. The tumor measured
5.5 × 4 × 2.5 cm and weighed 36 g. It was completely cov-
ered by skin including an area of showing hairy growth.
On cut section the tumor was composed of different
mature tissue structures including skin, hair, cartilage and
centrally located bone
There was no facial dysmorphy, cleft palate or other con-
genital anomalies. There was no pulmonary hypoplasia.
Histologic examination of the tumor showed variable
mature tissue types including bone with bone marrow,
hyaline cartilage, epidermis and thick dermis with hairy
follicles and sebaceous glands (Figure 3B–D). Subcutane-
ous fibro-fatty tissue contained skeletal muscle fascicles
(A, B): Histologic features of sinonasal teratocarcinosarcoma (Hematoxylin-eosin stain, maginification 20×) Figure 2
(A, B): Histologic features of sinonasal teratocarcinosarcoma (Hematoxylin-eosin stain, maginification 20×). 
(C): Cytogenetic analysis revealed a hyperploid clone characterized by trisomy 12. (D): An additional subclone contained also a 
deletion of the short arm of chromosome 1 (del1(p)).
A B
CD
B B
Table 1: Results of cytogenetic and FISH analyses of three multilineage tumors
Case Cytogenetics 12 p
FISH
1p36/1q25 FISH
TERATOCARCINO-SARCOMA 47, XX, +1218/
47, idem, del(1)(p31.1p36.3)
Not performed Not performed
SGAT Not performed Negative Negative
EPIGNATHUS Not performed Unsuccessful NegativeBMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
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and salivary glands. Part of the tumor consisted of mature
neuroglial tissue covered by leptomeningeal-like layer,
rich in blood-filled capillaries. The leptomeningeal-like
structures were lined by thin epidermal layer which was in
continuity with epidermal skin layer of main part of the
tumor. Histological composition of the tumor fully corre-
sponded to a solid mature teratoma (oronasopharyngeal
teratoma/epignathus). No atypical, immature or malig-
nant elements were found.
There was extensive intraalveolar, interstitial and subpleu-
ral hemorrhage in the immature pulmonary parenchyma
of both lungs, along with petechiae, confirming asphyxia
as a cause of death.
Cytogenetics
Fluorescent in-situ hybridization (FISH) with LSI DNA
probes for 1p36 and 1q25 was normal and did not iden-
tify chromosomal gains or losses in either. LSI ETV6 (TEL)
probe at 12p13 and a homebrew probe set for ETV6 and
CEP12 were unsuccessful.
Case 3
A 12-month old male presented with intermittent airway
obstruction and otitis media with bilateral middle ear
effusions. The clinical impression was of hypertrophied
adenoids, but on closer examination, a mass at the mid-
line posterior nasopharynx was discovered. It was excised
and submitted for pathologic examination.
Pathology Findings
A 1.7 × 1.0 × 0.6 cm lobulated, light gray to tan, fragment
of soft tissue was received for examination. Histopatho-
logic examination revealed a tumor covered by stratified
squamous epithelium that extended into the stroma
forming a submucosal network of branching tubular
(A): Gross appearance of the epignathus with tongue-like structures with the blunt border and skin-like surface Figure 3
(A): Gross appearance of the epignathus with tongue-like structures with the blunt border and skin-like sur-
face. (B-D): Histopathologically, the tumor was composed of different mature teratomatous tissue including brain (B), bone 
with moderately cellular bone marrow (C), epidermis with numerous hairy follicles and sebaceous glands (D).
A
C
B
DBMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
Page 7 of 10
(page number not for citation purposes)
structures. These ducts were lined by cuboidal or low
columnar epithelium that frequently was transformed
into squamous-type lining. The stroma was predomi-
nately densely collagenous with myoepithelial cells; focal
areas of loose, myxoid stroma (that contained plasma
cells) were also present (Figure 4A–B). No cartilaginous or
other heterologous elements were found. Immunohisto-
chemical analysis revealed diffuse expressions of cytok-
eratins (AE1/3 and CK5/6) in the branching ductal
epithelium and focal expression among myoepithelial
cells. Both structures expressed smooth muscle actin
(SMA) and vimentin (Figure 4C).
Cytogenetics
Fluorescent in-situ hybridization (FISH) with LSI DNA
probes for 1p36 or 1q25 was normal and did not identify
chromosomal gain or loss in either region. LSI ETV6 (TEL)
probe at 12p13.2 and a homebrew probe set for ETV6 and
CEP12 were also normal showing 2 copies per cell nucleus
(Figure 4D).
Discussion
This study reports three new cases of upper respiratory
tract tumors, all showing complex, and multilineage his-
tology. The tumors are reported in patients of diverse ages,
with significantly varied clinical signs. The presentation of
each lesion reflected in part the age of the patient, severity
of disease and the biological potential of the tumor. The
histologically mature (benign) congenital oronasopha-
ryngeal teratoma (epignathus) caused death from upper
airway obstruction in a neonate. The highly malignant
SNTCS in an 85-year-female had delayed diagnosis and
treatment due to insidious development in the upper res-
piratory tract and also resulted in the fatal outcome. A
(A,B): Histological features of salivary gland anlage tumor (Hematoxylin-eosin stain, magnification 10×) Figure 4
(A,B): Histological features of salivary gland anlage tumor (Hematoxylin-eosin stain, magnification 10×). (C): 
Smooth muscle actin staining highlights both ductal epithelium and myoepithelial cells. (D): FISH analysis revealed 2 copies of 
12p13.2 and 12 centromeres with no loss or gain of 1p36 or 1q25.
A
C
B
D DBMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
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hamartomatous SGAT was diagnosed in a 12 month old
male and prompt appropriate treatment avoided poten-
tially life-threatening severe respiratory distress and feed-
ing difficulties [26].
The biologic potential of germ cell tumors generally corre-
lates with their gain of chromosomal aberrations. These
aberrations are detectable by conventional cytogenetics
when fresh tissue is available for cultures. Additionally
fluorescent in-situ hybridization (FISH) can be used to
detect these abnormalities in formalin fixed paraffin
embedded tissues. In our cases we were able to perform
cytogenetic analysis on SNCTS and identify trisomy of 12
with a subpopulation of cells showing additional deletion
of 1p chromosome. These are the first reported cytoge-
netic abnormalities found in SNTC.
Trisomy 12, as a primary or secondary event, is a well
known cytogenetic abnormality occurring in majority of
malignant germ cell tumors [1,27]. The finding of trisomy
12 in our case of SNTCS supports the hypothesis that
SNTCS has the germ cell origins though Salem et al [6]
recently reported three cases of SNTCS with no amplifica-
tion of chromosome 12p, thus questioning the germ cell
origins of SNTCS. We also want to point out that our case
of SNTCS bore an additional finding in a form of the dele-
tion of 1p chromosome in a subclone of SNTCS. Loss of
1p is a well characterized genetic feature of embryonal
tumors, particularly pediatric germ cell tumors as well as
among malignant GCT where it is associated with aggres-
sive clinical course and a poor prognosis [23,28,29].
Notably, loss of 1p (like a gain of chromosome 12p) has
also been detected in many other malignant tumor types
(e.g. neuroblastoma, ductal breast carcinoma, colorectal
carcinoma, malignant melanoma, Wilm's tumor, and
endometrial carcinoma), prompting Bussey et al [23] to
propose that the loss of 1p (or gain of 1q) in case of pedi-
atric germ cell tumors might be indicative of malignancy
and also might serve as a prognosticator of a worse out-
come. Obviously, additional cases need to be analyzed to
confirm our hypothesis since it is also suggested that
SNTCS originates from primitive totipotential cells in the
olfactory/sinonasal membrane, capable of differentiation
into divergent types of somatic cells [3].
In our cases, neither the SGAT nor epignathus carried such
cytogenetic aberrations. This result combined with its his-
topathological and clinical features of SGAT support the
thesis that SGAT might be a hamartomatous, develop-
mental disorder rather than true neoplastic lesion. A study
of  Bussey et al [23] concluded that the gonadal and
extragonadal teratomas, both mature and immature of
children four years and younger, mainly carried normal
karyotype without cytogenetic abnormalities though sev-
eral papers reported diverse cytogenetic abnormalities
even in congenital mature teratomas including epignathi
[30,31].
Histologically, SNTCS is composed of various tissues
including epithelial, mesenchymal, and neural elements
including teratoid elements. SNTCS lacks features of
embryonal carcinoma, choriocarcinoma, and seminoma
[3]. This characteristic distinguishes SNTCS from other
malignant germ cell tumors. It is noteworthy that malig-
nant teratomas usually do not exhibit the carcinosarcoma-
tous features, present in SNTCS [3] although it is certainly
recognized that a sarcomatous component might be
present in some malignant germ cell tumors [32]. Because
of its heterogeneous composition, the diagnosis of SNTCS
can be quite challenging, particularly if the sampling is
not sufficient. Other tumors that may be considered
include primarily olfactory neuroblastoma, squamous
cell carcinoma, adenocarcinoma, neuroendocrine carci-
noma, sarcoma, blastomatous tumors with teratoid fea-
tures, and craniopharyngeoma [3,33,34]. One feature that
seems to be highly suggestive of SNTCS is the presence of
the "fetal-appearing" clear cell squamous epithelium [35].
In our opinion this feature also supports the teratoid
nature of the tumor.
SGAT is quite rare tumor with only 24 cases (including the
case presented in this paper) described since Dehner et al
[20] introduced this entity. Thus, SGAT is one of the rarest
causes of neonatal nasal airway obstruction, and is rarer
than congenital tumors like epignathus whose incidence
is estimated to be 1:35.000 to 1:200.000 live births [12].
The majority of patients with SGAT present with symp-
toms (typically respiratory distress and hypoxia) in the
neonatal period or first weeks of the life. Our case is the
first described with delayed presentation (12 months) and
the oldest previously described patient presented with the
tumor at the age of three months [22]. For unknown rea-
sons, SGAT is much more prevalent among males and this
was supported in our case.
Histopathological features of SGAT include the presence
of the stratified squamous epithelium that extends into a
loose, myxoid stroma forming a submucosal network of
branching tubular structures (tubular to cord-like epithe-
lial structures). Areas with necrosis and cystic degenera-
tion might also be present [22]. Only one case with a
widespread necrosis and large cyst formations has been
described to date [36]. Many other hamartomatous and
teratoid lesions may arise in sinonasal region including
mesenchymal, adenomatoid, and glandular hamartomas
depending on the predominance of the specific structures
[2].BMC Ear, Nose and Throat Disorders 2008, 8:8 http://www.biomedcentral.com/1472-6815/8/8
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SGAT exhibits benign behavior and no recurrences after
complete surgical resection were reported in the literature
[26]. It may be accompanied by other midline develop-
mental disorders in the head and neck region including
dermoid sinus, nasal glioma, and thyroglossal duct cyst
[22].
Teratomas have origins in totipotential germ cells and
along with neuroblastoma they are the most common
congenital tumors. Nevertheless, head and neck (orona-
sopharyngeal) teratomas are exceptionally rare compris-
ing less than 2% of all congenital teratomas [37]. They are
characteristically composed of different tissue types from
different germ cell layers. Teratomas are histologically
classified as either mature or immature, where immature
elements consist mainly of primitive neuroglial tissue and
neuroepithelial rosettes. Histopathological analysis of our
tumor revealed no immature neural or other tissue ele-
ments, thus classifying it as a mature (benign) teratoma
(epignathus). This is in concordance with other studies
since the most epignathi are benign with extremely rare
malignant alteration [38].
Our case of epignathus provides lessons for both diagno-
sis and care of patients with this tumor. Uncharacteristi-
cally, the tumor was not associated protrusion from the
oral cavity, intracranial extension or other midline anom-
alies including cleft palate as the most common anomaly
associated with epignathus [13,17]. Nevertheless the
growth pattern was very specific with the tumor filling the
oral cavity and upper aerodigestive tract. In our case this
one feature prevented successful intubation after birth
and caused death from what might otherwise have been
considered a benign neoplasm. If the diagnosis can be
established, future cases may consider alternative treat-
ment approaches including a recently developed EXIT
procedure to allow for survival of the newborn. Multidis-
ciplinary approach should always be used, although suc-
cessful treatment and outcome from these lesions is likely
to remain challenging [39].
Conclusion
The comparison of these three cases should serve to
emphasize the diversity of multilineage tumors (hamarto-
mas and GCT) of the upper respiratory tract in regards to
their biology, age of presentation and clinical outcomes.
Malignant tumors of germ cell origins are more likely to
affect adults with insidious symptom development, while
benign tumor can nevertheless cause dramatic clinical
symptoms which, under certain circumstances, can be
fatal.
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